Diagnosis, clinical assessment, and staging of hepatocellular carcinoma: a Brazilian multidisciplinary consensus.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Coimbra Felipe José Fernández, Godoy André Luís de, Fernandes Paulo Henrique de Sousa, Feitosa Neto Heládio, Pinheiro Rodrigo Nascimento, Boin Ilka de Fátima Santana Ferreira, Andraus Wellington, Tustumi Francisco, Amaral Paulo Cezar Galvão do, Brandão Mello Carlos Eduardo, Braun Alexcia Camila, Braghiroli Maria Ignez, Bredt Luis César, Caparroz Carla, Carrilho Flair José, Cunha Guilherme Moura, Diniz Alessandro Landskron, Forte Daniel Neves, Garcia José Huygens Parente, Genzini Tércio, Correia Mauro Monteiro, Oliveira Cássio Virgílio Cavalcante de, Kalil Antonio Nocchi, Lima Agnaldo Soares, Martins Guilherme Lopes Pinheiro, Rocha Cristina Melo, Menezes Marcos Roberto de, Motta-Leal-Filho Joaquim Maurício da, Murad Júnior Munir, Peixoto Renata D'Alpino, Pinheiro Rafael Soares, Rezende Marcelo Bruno, Ribeiro Héber Salvador de Castro, Martins Mario Rino, Rocha Filho Duilio Reis da, Rosa Arthur Accioly, Szutan Luiz Arnaldo, Torres Orlando Jorge Martins, Carneiro D'Albuquerque Luiz Augusto, Mattos Ângelo Alves de, Coutinho Anelisa Kruschewsky, Herman Paulo, Oliveira Alexandre Ferreira
Аннотация
AIM: To develop evidence-based, multidisciplinary recommendations to guide the diagnosis, clinical assessment, and staging of patients with HCC.
METHODS: This consensus was developed by 43 experts from surgical oncology, hepatology, clinical oncology, radiology, interventional radiology, pathology, liver transplantation, gastroenterology, radiation oncology, and palliative care, under the coordination of the Brazilian Society of Surgical Oncology and 13 collaborating national medical societies. A scientific steering committee predefined clinically relevant questions addressing radiological and histopathological diagnosis, clinical assessment, diagnostic work-up, management of patients at the time of HCC diagnosis, and staging. These questions were discussed and refined in multidisciplinary meetings and submitted to structured voting rounds.
RESULTS: The panel formulated 18 recommendations covering key aspects of HCC evaluation, including standardized application of Liver Imaging Reporting and Data System (LI-RADS®) for imaging-based diagnosis, management of indeterminate lesions, indications for biopsy, histopathological classification and reporting, immunohistochemical markers, assessment of hepatic function and portal hypertension, staging systems, diagnostic work-up, and the role of multidisciplinary care. The recommendations emphasize integration of imaging findings with liver-related factors and clinical context to support individualized decision-making.
CONCLUSIONS: This multidisciplinary consensus provides practical, evidence-based recommendations for the diagnosis, clinical assessment, and staging of HCC. By promoting standardized diagnostic practices while reinforcing comprehensive patient evaluation and multidisciplinary management, this document aims to improve diagnostic accuracy, optimize treatment selection, and support safe care.